Detection of collagen type II and proteoglycans in the synovial fluids of patients diagnosed with non-infectious knee joint synovitis indicates early damage to the articular cartilage matrix

Osteoarthritis and Cartilage

Volumn 11, Issue 9, 2003, Pages 673-680

  Elsaid, K A ^a   Jay, G D ^b   Chichester, C O ^a  

^a UNIVERSITY OF RHODE ISLAND   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

Cartilage; Collagen type II; Osteoarthritis; Synovitis

Indexed keywords

ANILIDE; BIOLOGICAL MARKER; COLLAGEN ANTIBODY; COLLAGEN TYPE 2; COLLAGEN TYPE 3; COLLAGEN TYPE 5; COLLAGENASE; DYE; ELASTASE; EPITOPE; GLYCOSAMINOGLYCAN POLYSULFATE; KERATAN SULFATE; LEUKOCYTE ELASTASE; MONOCLONAL ANTIBODY; PROTEOGLYCAN;

AMINO ACID SEQUENCE; ARTICLE; ARTICULAR CARTILAGE; ASPIRATION; BINDING ASSAY; CARTILAGE DEGENERATION; CARTILAGE MATRIX; CHRONIC ARTHRITIS; CLINICAL ARTICLE; COLORIMETRY; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME SUBSTRATE; HUMAN; KNEE; KNEE INJURY; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEGRADATION; QUANTITATIVE ASSAY; RHEUMATOID ARTHRITIS; STATISTICAL SIGNIFICANCE; SYNOVIAL FLUID; SYNOVITIS;

EID: 0041384370     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1063-4584(03)00151-1     Document Type: Article

References (23)

1. Heinegard D, Oldberg A. Structure and biology of cartilage and bone matrix noncollagenous macromolecules. FASEB J 1989;3:2042-51.
2. Billinghurst RC, Dahlberg L, Ionescu M, Reiner A, Bourne R, Rorabeck C, et al. Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. J Clin Invest 1997;99:1534-45.
3. Migita K, Eguchi K, Kawabe Y, Ichinose Y, Tsukada T, Aoyagi T, et al. TNF-alpha-mediated expression of membrane-type matrix metalloproteinase in rheumatoid synovial fibroblast. Immunology 1995;89:553-7.
4. Lark MW, Bayne EK, Flanagan J, Harper CF, Hoerrner LA, Hutchinson NI, et al. Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints. J Clin Invest 1997;100:93-106.
5. Srinivas GR, Barrach HJ, Chichester CO. Quantitative immunoassays for type II collagen and its cyanogens bromide peptides. J Immunol Methods 1993;159: 53-62.
6. Otterness IG, Downs JT, Lane C, Bliven ML, Stukenbrok H, Scampoli DN, et al. Detection of collagenase-induced damage of collagen by 9A4, a monoclonal C-terminal neoepitope antibody. Matrix Biol 1999;18:331-41.
7. Felice BR, Chichester CO, Barrach HJ. Type II collagen release from rabbit articular cartilage. Ann N Y Acad Sci 1999;878:590-3.
8. Gelber AC, Hochberg MC, Mead LA, Wang NY, Wigley FM, Klag MJ. Joint injury in young adults and risk for subsequent knee and hip osteoarthritis. Ann Intern Med 2000;133:321-8.
9. Barrach HJ, Chichester CO, Sargent DA, Saracen MJ, Griggs S, Hulstyn M, et al. Quantification of collagen type II peptides in synovial fluid by inhibition ELISA. Trans Orthop Res Soc 1996;21:218.
10. Bitter T, Muir HM. A modified uronic acid carbazole reaction. Anal Biochem 1962;4:330-4.
11. Le Graverand M, Eggerer J, Sciore P, Reno C, Vignon E, Ottterness I, et al. Matrix metalloproteinase-13 expression in rabbit knee joint connective tissues: influence of maturation and response to injury. Matrix Biol 2000;19:431-41.
12. Hazell PK, Dent C, Fairclough JA, Bayliss MT, Hardingham TE. Changes in glycosaminoglycan epitope levels in knee joint fluid following injury. Arthritis Rheum 1995;38:953-9.
13. Farndale RW, Buttle DJ, Barrett AJ. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta 1986;883:173-7.
14. Chevalier X, Groult N, Texier JM, Larget-Piet B, Hornebeck W. Elastase activity in cartilage extracts and synovial fluids from subjects with osteoarthritis or rheumatoid arthritis: the prominent role of metalloproteinases. Clin Exp Rheumatol 1996;14: 235-41.
15. Konittinen YT, Ainola M, Valleala H, Ma J, Ida H, Mandelin J, et al. Analysis of 16 different metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: different profiles in trauma and rheumatoid arthritis. Ann Rheum Dis 1999;58:691-7.
16. Havemann K, Gramse M. Physiology and pathology of neutral proteinases of human granulocytes. Adv Exp Med Biol 1984;164:1-20.
17. Gadher S, Eyre D, Duance V, Wotton S, Heck L, Schmid T. Susceptibility of cartilage collagens type II, IX, X and XI to human synovial collagenase and neutrophil elastase. Eur J Biochem 1988; 175:1-7.
18. Ferry G, Lonchampt M, Pennel L, De Nanteuil G, Canet E, Tucker G. Activation of MMP-9 by neutrophil elastase in an in vivo model of acutelung injury. FEBS Lett 1997;402:111-5.
19. Itoh Y, Nagase H. Preferential inactivation of tissue inhibitor of metalloproteinase-1 that is bound to the precursor of matrix metalloproteinase 9 (progelatinase B) by human neutrophil elastase. J Biol Chem 1995;270:16518-21.
20. Momohara S, Kashiwazaki S, Inoue K, Saito S, Nakagawa T. Elastase from polymorphonuclear leukocyte in articular cartilage and synovial fluids of patients with rheumatoid arthritis. Clin Rheumatol 1997;16:133-40.
21. Hugo J, Taurog J. Mechanisms of disruption of the articular cartilage surface in inflammation: neutrophil elastase increases availability of collagen type II epitopes for binding with antibody on the surface of articular cartilage. J Clin Invest 1991;87:1531-6.
22. Ratcliffe A, Doherty M, Miani RN, Hardingham T. Increased concentrations of proteoglycan components in the synovial fluids of patients with acute but not chronic joint disease. Ann Rheum Dis 1988; 47:826-32.
23. Bayliss MT, Venn M, Maroudas A, Ali SY. Structure of proteoglycanas from different layers of human articular cartilage. Biochem J 1983;209:387-400.